AN2 Therapeutics, Inc. (ANTX )

Currency in USD Disclaimer
$5.15 -$0.08 (-1.44%)
Open 11/20/2026
$4.96
$5.49
$1
$7.19

Company brief: AN2 THERAPEUTICS, INC. (ANTX )


AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menlo Park, California.

ANTX Corporation News

Income Statement